CompoAtlas

Cholesterol Command

Finding published by the FDA

Finding published by the FDA

Finding date: 14 November 2022.

New Drug/Misbranded

FDA finding date
14 November 2022
Company
BergaMet North America LLC
Subject published by the FDA
New Drug/Misbranded
Published action
Warning Letter
Programme
Foods

This official finding is dated and does not necessarily describe the product currently sold under this name. It does not constitute an analysis of its complete composition.

The subject and action are reproduced as published by the FDA, without generalisation to all batches or other products from the company.

Substances named in the FDA finding

No individual substance identified in the subject of this finding.

Substances named in the FDA finding do not constitute a complete composition. No quantity or dose is inferred.

Sites cited by the FDA

bergametna.com

Official source

View the FDA finding

Food and Drug Administration, Health Fraud Product Database. Dated official findings.

Domaine public (politique du site FDA)

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Cholesterol Command”, https://compoatlas.com/en/supplements/us-fraud/0a811b311b8153b612483f6566db6d2e259fa12ddccb8f12f01dde96259e3949-cholesterol-command, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line